1. Home
  2. PBH

as 11-07-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Founded: 1996 Country:
United States
United States
Employees: N/A City: TARRYTOWN
Market Cap: 3.3B IPO Year: 2005
Target Price: $86.40 AVG Volume (30 days): 410.8K
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 4.04 EPS Growth: -1.41
52 Week Low/High: $59.51 - $90.04 Next Earning Date: 11-06-2025
Revenue: $1,110,479,000 Revenue Growth: -0.02%
Revenue Growth (this year): -2% Revenue Growth (next year): 2.69%

PBH Daily Stock ML Predictions

Share on Social Networks: